The rapid diagnosis of CNS infection with herpes simplex virus (HSV) is important because of the potential morbidity and mortality associated with HSV encephalitis (HSVE) and the availability of antiviral therapy (acyclovir) that is proven to ameliorate this disease. Without therapy, 170% of HSVE cases are fatal and ∼11% of surviving patients recover normal function [1, 2] . Treat-
ment with acyclovir has been shown to reduce the mortality rate to ∼20% for patients of all ages [3, 4] .
The broad spectrum of clinical syndromes associated with HSV infection of the CNS most commonly presents as 1 of 3 general entities: neonatal infection, encephalitis, or meningitis. Neonatal HSV infection, usually with dissemination and a mortality rate similar to that for HSVE, is most often caused by HSV type 2 (HSV-2) transmitted vertically during delivery [5] . HSVE presents with an acute onset, localized CNS findings, and necrosis of brain parenchyma (classically of the temporal and/or frontal lobes) and may occur in patients of any age beyond the neonatal period. It is the most common cause of sporadic fatal encephalitis in the United States (an incidence of 1 case per 250,000-500,000 persons per year) [6] and is predom-inantly caused by HSV type 1 (HSV-1; 185% of cases) [7] [8] [9] . Viral meningitis caused by HSV (HSVM) is a self-limited illness of 2-5 days' duration characterized by CSF findings of pleocytosis and an elevated protein level with a normal glucose level. The number of cells in the CSF may have a range of 5-3000 cells/mm 3 , but it is usually 100-400 cells/mm 3 with lymphocyte predominance. HSVM is commonly caused by HSV-2 infection, and a recent study demonstrated a predominance in young adult women, with a ratio of affected women to affected men of 6:1 [9] . It is also reported to be a sequela of primary genital herpes in 36% of affected women and 13% of affected men [10] , but only 25%-33% of patients with HSVM ever report a history of genital lesions [11, 12] . A subset of these patients, possibly as many as 25% [9, 13] , have recurrent bouts of HSVM separated by asymptomatic periods that last from months to years, a syndrome first described by Mollaret in 1944 [14] .
Traditional methods of detection for laboratory diagnosis of HSV infection of the CNS are either extremely invasive (brain biopsy with culture or antigen detection in tissue specimens [8, 15] ) or insensitive (culture of CSF specimens yields positive results in only 4% of biopsy-proven cases of HSVE [8] ) or they lack clinical significance (HSV antibody levels in CSF take 1-4 weeks to reach diagnostic levels [8, 13, 16, 17] ). Since the initial PCR-based detection of HSV DNA in CSF specimens obtained from patients with HSVE by Rowley et al. [18] in 1990, numerous reports of the utility of PCR for the diagnosis of HSVE [19] [20] [21] [22] [23] [24] [25] [26] [27] and HSVM [9, 12, [27] [28] [29] [30] [31] [32] have been published. In patients with HSVE, PCR-based detection of HSV DNA in CSF specimens has sensitivity and specificity comparable or superior to those of brain biopsy, and it is now considered the reference standard for the laboratory diagnosis of HSVE [19, 27] . With PCR-based detection, HSV-2 DNA has also been reported in an increasing number of patients with recurrent meningitis [7, 9, 12, 13, [27] [28] [29] .
PCR has been used to detect HSV DNA in the CSF of patients who present with "atypical" clinical syndromes. PCR detection has facilitated the diagnosis of mild atypical meningoencephalitis, a syndrome possibly due to HSV infection and/or reactivation that is characterized by meningeal and neurological signs that spontaneously resolve without sequelae [7, 33, 34] . PCR-based detection of HSV DNA in CSF specimens obtained from patients with radiculomyelitis has also been reported [35, 36] . Bell's palsy [37, 38] , cluster headaches [39, 40] , migraines [41] , and even common recurrent headaches [42] all have been suggested to have HSV infection or reactivation as a cause. PCR-based detection may identify those patients who could benefit from antiviral therapy.
This study reports the experience of PCR-based detection of HSV DNA in CSF specimens with an assay developed "in house" at a large, urban general hospital. The purpose was to correlate laboratory findings in CSF with clinical presentations and histories to better define CNS disease due to HSV infection and to improve laboratory diagnosis.
METHODS
Samples were submitted from 3 hospitals in the Partners Healthcare System (Boston): 2 large, urban academic medical centers and 1 suburban community hospital. The method used for HSV DNA amplification was modified from the method of Espy et al. [43] with use of primers complementary to a region of the DNA polymerase gene specific for HSV: 5 -TACATCGG-CGTCATCTGCGGGG-3 and 5 -CAGTTCGGCGGTGAGGA-CAAAG-3 . The primers produce a 291-bp amplicon that cannot discriminate between HSV-1 and HSV-2 [44] . DNA was isolated from 200 mL of a CSF specimen by use of the QIAamp DNA isolation kit (Qiagen). Negative controls (water as DNA template) and positive controls were included with each assay. Positive controls were a mixture of either HSV-1 or HSV-2 DNA (VR-539 or VR-540, respectively; American Type Culture Collection) diluted to the detection limit of the assay (60 copies of template DNA per reaction). Sample specimens spiked with positive control DNA were also run in parallel to control for the presence of PCR inhibitors in human CSF, but this procedure was discontinued in January 1999 because of the low level of inhibition detected (only 3 [0.67%] of 446 samples).
Amplicons were electrophoresed in 2% agarose gels and stained with ethidium bromide. Amplicons comparable in size to the positive control (291 bp) were processed for confirmation by ApaI restriction digestion. A positive result for HSV-1 or HSV-2 digested by ApaI yielded 96-bp and 195-bp fragments. Once the test yielded a confirmed positive result, clinical and laboratory data for the case were reviewed retrospectively. Clinical data were obtained from discharge summaries written by the admitting house staff and by telephone when the positive results were reported to the clinician. Clinical and laboratory data were obtained for 54 cases. On the basis of the clinical diagnosis, cases were divided into 4 categories: neonatal infection, severe encephalitis (HSVE), a milder atypical meningoencephalitis, and meningitis (HSVM). Differences of the mean values between the HSVE and HSVM groups were analyzed with a 2-tailed t test.
Most CSF specimens submitted to the laboratory for HSV PCR were assayed without established acceptance criteria. This policy was changed on 1 September 2000 to a requirement of a CSF leukocyte count of 15 cells/mm 3 and/or an abnormally elevated CSF protein level (155 mg/dL). This policy was implemented after a retrospective review of local hospital cases and publication of a report that failed to demonstrate HSV DNA-positive cases without abnormal CSF findings [45] . If clinical suspicion of virus-associated CNS infection was an ur- gent consideration, the physician contacted the laboratory, and HSV PCR amplification was done despite the patient having normal CSF parameters. Protocols for review of medical records and laboratory data were approved by the Human Research Committee of the Massachusetts General Hospital (IRB 2001-P-000828/1). specimens were submitted and 153 were rejected on the basis of test criteria. Ten of the specimens tested positive for HSV DNA, which is 2.5% of the submitted specimens and 4.0% of the tested specimens, and which represents a 2-fold increase in the positivity rate after implementation of the test criteria. Test utilization improved, with a 38% reduction in the number of specimens analyzed after implementation of these acceptance criteria.
RESULTS

From
Of Sixteen cases of HSVE (29% of all positive cases) were identified, and patients had an age range of 1.3-86 years (mean, 57.2 years) and a ratio of male to female patients of 1:1.3. Clinical information was available for 15 of the 16 cases of HSVE. All of these patients presented with mental status changes and/or seizures, and 14 of 15 also had documented fever. CT or MRI of the brain also demonstrated abnormalities consistent with HSV infection in 14 of 15 cases. Culture of CSF specimens for virus were performed for 5 patients, but only 1 specimen yielded virus (HSV-1 in the patient with herpes labialis). All of the patients with HSVE received acyclovir, and 3 died despite receiving therapy. Ten of the 13 survivors required transfer to rehabilitation facilities when they were discharged from the hospital.
Thirty-four cases of HSVM (62% of HSV DNA-positive cases) were documented in 33 patients. Ages ranged from 20 to 66 years (mean, 37.9 years) with a ratio of male to female patients of 1:2.8. All patients with HSVM presented with headaches, and a majority also presented with fever and/or men- ingismus ( and 20, respectively). Photophobia and/or n p 22 nausea or vomiting were reported in 35% and 44% of patients, respectively. Only 5 patients had skin lesions suggestive of herpes simplex (4 patients had genital lesions and 1 patient had oral lesions). Five cultures of CSF specimens for virus were performed, and 1 specimen yielded virus (HSV-2 in a patient with no history or symptoms of genital herpes simplex). Twelve patients underwent brain imaging studies, but in contrast to the results for patients with HSVE, none of the results were positive. Fourteen patients with HSVM (41% of all HSVM cases) reported recurrent headaches, "migraines," or aseptic meningitis. One patient (a 32-year-old woman) had HSV DNA-positive CSF specimens during her second and third episodes of meningitis, which were 7 months apart. She was not tested for HSV DNA during her first episode 2 years before and had no history of genital herpes.
A single case of disseminated neonatal infection (data not shown) occurred in a baby born during the 33rd week of gestation after preterm premature rupture of membranes. He developed a vesicle on his scalp a few days after delivery that culture verified was due to HSV-2 infection. He developed apnea at 8 days of age, and PCR of a CSF specimen yielded positive results for HSV DNA. Laboratory studies of CSF specimens also revealed an elevated leukocyte count and protein level (WBC count, 570 cells/mm 3 ; protein level, 242 mg/dL). This patient survived after receiving acyclovir therapy.
Three cases with positive results of PCR for HSV DNA in CSF were diagnosed as mild atypical meningoencephalitis. Laboratory analysis of CSF specimens obtained from all 3 patients showed elevated leukocyte counts with lymphocyte predominance and elevated protein levels (CSF WBC count, 300-730 cells/mm 3 . CSF protein levels were also lower in patients with HSVE (mean, 73 mg/dL) than they were in patients with HSVM (mean, 129 mg/ dL;
). Four patients with HSVE (25%) had CSF protein P ! .0001 levels of !55 mg/dL (range, 22-48 mg/dL), which is the upper limit of normal for this laboratory. There was no significant difference in the number of RBCs in CSF between the 2 groups: although several patients with HSVE had markedly elevated RBC counts (15000 cells/mm 3 ), for 6 patients, the RBC count was р3 cells/mm 3 .
DISCUSSION
This study represents the first direct comparison of CSF laboratory findings for HSV encephalitis and meningitis in patients with known HSV DNA status. The results demonstrate that elevations in CSF WBC cell counts and protein levels are greater in cases of HSVM than they are in cases of HSVE. CSF RBC counts were unreliable in distinguishing patients with HSVE from those with HSVM: although RBC counts were markedly elevated (15000 cells/mm 3 ) in CSF specimens obtained from several patients with HSVE, 6 had RBC counts of р3 cells/ mm 3 . In all HSV DNA-positive cases, patients had elevated leukocyte counts or protein levels in CSF, regardless of clinical presentation. This suggests that prescreening of CSF specimens may be used to improve test utilization. The subtle CSF abnormalities seen in some cases of HSVE (especially those with minimal numbers of CSF erythrocytes) indicate that caution should be exercised when screening specimens obtained from patients with suspected cases of HSV infection prior to PCR amplification. This cautious approach is particularly important earlier in disease presentation or among immunocompromised patients, because HSVE with normal CSF parameters has been reported in immunocompromised patients [7] . In 1999, Tang et al. [45] first demonstrated the use of CSF parameters to screen specimens before PCR analysis for HSV DNA detection. Of 723 CSF specimens tested for HSV DNA, none of the 24 positive specimens had CSF leukocyte counts of !5 cells/mm 3 and CSF protein levels of !45 mg/dL [45] . They also showed that, by screening CSF specimens a priori for leukocyte counts and protein levels with use of these criteria, they could reduce their workload by 29% without missing any HSV-positive CSF specimens [45] . Our experience showed that, after introduction of test criteria, a 38% reduction in the number of specimens analyzed was realized without a proportional decrease in the number of positive results. The positivity rate was 4.0%, approaching the rates (7.1% and 7.6%) obtained when the test was specifically used for cases with a high degree of suspicion for HSV in prior studies [7, 27] .
Comparison of CSF laboratory findings demonstrates milder abnormalities in HSVE than in HSVM and suggests that care should be taken when interpreting CSF findings in patients with encephalitis. A prior report correlated CSF findings with HSV type among patients with HSV DNA detected in CSF specimens by PCR and demonstrated similar results [32] . They detected HSV DNA in 33 (1.5%) of 2233 specimens submitted; 20 specimens had HSV-1, 6 had HSV-2, and 7 had HSV-1 or -2. From prior experience [7] [8] [9] , it can be assumed that the cases due to HSV-1 were predominantly encephalitis, and CSF leukocyte counts ranged from 0 to 575 cells/mm 3 (mean, 102 cells/mm 3 ) and CSF protein levels ranged from 30 to 130 mg/ dL (mean, 98 mg/dL). Cases due to HSV-2, which are most likely HSVM, were associated with CSF leukocyte counts ranging from 116 to 1188 cells/mm 3 (mean, 553 cells/mm 3 ) and CSF protein levels ranging from 86 to 170 mg/dL (mean, 110 mg/dL) [32] .
PCR-based detection of CNS infections with HSV has yielded increased appreciation of mild CNS disease, including HSVM. Almost one-half (41%) of the patients with HSVM described here had prior CNS symptoms in the form of aseptic meningitis and/or recurrent headaches or "migraines," even though only 15% reported a history of herpetic rash. With the identification of more patients having recurrent meningitis associated with HSV infection by use of PCR of CSF to detect HSV, it is possible to identify patients with mild disease and to determine whether antiviral therapy offers any therapeutic advantage to such patients. Anecdotal reports have already suggested that acyclovir may reduce recurrences of symptoms in such patients [46, 47] .
In summary, abnormalities (elevated CSF leukocyte count and/or protein level) were present in all CSF specimens that were positive for HSV DNA by PCR. These CSF abnormalities were milder in cases of HSVE than in cases of HSVM, especially when minimal numbers of CSF erythrocytes were also present. Nevertheless, the findings indicate that CSF parameters may be used to screen specimens before analysis for HSV DNA by PCR. However, caution should be exercised when the patient is immunocompromised, because the patient may have HSVE with normal CSF parameters.
